Nothing Special   »   [go: up one dir, main page]

UA44558U - Method for diagnosis of pharmacoresistant first-generalized epilepsy - Google Patents

Method for diagnosis of pharmacoresistant first-generalized epilepsy

Info

Publication number
UA44558U
UA44558U UAU200903567U UAU200903567U UA44558U UA 44558 U UA44558 U UA 44558U UA U200903567 U UAU200903567 U UA U200903567U UA U200903567 U UAU200903567 U UA U200903567U UA 44558 U UA44558 U UA 44558U
Authority
UA
Ukraine
Prior art keywords
pharmacoresistant
diagnosis
generalized epilepsy
immunofluorescent
antibodies
Prior art date
Application number
UAU200903567U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Евгения Владимировна Лекомцева
Original Assignee
Государственное Учреждение "Институт Неврологии, Психиатрии И Наркологии Амн Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Неврологии, Психиатрии И Наркологии Амн Украины" filed Critical Государственное Учреждение "Институт Неврологии, Психиатрии И Наркологии Амн Украины"
Priority to UAU200903567U priority Critical patent/UA44558U/en
Publication of UA44558U publication Critical patent/UA44558U/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to a method for diagnosis of pharmacoresistant first-generalized epilepsy on the base of the data of thermal τ-protein content in the blood serum. Thr immunofluorescent method is used, where the determination of τ-protein concentration is carried out in immunofluorescent reaction with the use of primary monoclonal mouse anti-τ antibodies and second monoclonal antibodies of IGG (γ) FITC.
UAU200903567U 2009-04-13 2009-04-13 Method for diagnosis of pharmacoresistant first-generalized epilepsy UA44558U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200903567U UA44558U (en) 2009-04-13 2009-04-13 Method for diagnosis of pharmacoresistant first-generalized epilepsy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200903567U UA44558U (en) 2009-04-13 2009-04-13 Method for diagnosis of pharmacoresistant first-generalized epilepsy

Publications (1)

Publication Number Publication Date
UA44558U true UA44558U (en) 2009-10-12

Family

ID=50636571

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200903567U UA44558U (en) 2009-04-13 2009-04-13 Method for diagnosis of pharmacoresistant first-generalized epilepsy

Country Status (1)

Country Link
UA (1) UA44558U (en)

Similar Documents

Publication Publication Date Title
EA201170229A1 (en) CONTINUOUS METHOD FOR CONVERSING NATURAL GAS TO LIQUID HYDROCARBONS
SG195073A1 (en) Deimmunized serum-binding domains and their use for extending serum half-life
MY182750A (en) Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
WO2009128963A3 (en) Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
WO2009126934A3 (en) Detection and tratment of pancreatic, ovarian and other cancers
IN2012DN05237A (en)
MX360352B (en) Fc-receptor based affinity chromatography.
EA201500219A1 (en) ANTIBODY AGAINST TROP-2 PERSON HAS ANTI-TUMOR ACTIVITY IN VIVO
PH12014502054B1 (en) Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
MY189968A (en) Monoclonal antibody, and immunoassay using the same
MX2010002683A (en) Homogeneous antibody populations.
MX2018013008A (en) Soluble human st-2 antibodies and assays.
NZ610267A (en) A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use
WO2009114603A3 (en) Diffusion tensor imaging confidence analysis
EP1855719A4 (en) Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
BRPI1005176A2 (en) insulin assay, insulin assay reagent, monoclonal antibody, and method of screening monoclonal antibodies.
MX2013007527A (en) Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same.
MX2016005686A (en) Competitive ligand binding assay for detecting neutralizing antibodies.
WO2009008414A1 (en) Monoclonal antibody having neutralizing activity against mmp13
EP2565647A4 (en) Reagent for assaying anti-treponema pallidum antibody
UA109148C2 (en) Compositions based on anti-vegfr-3 antibody
UA44558U (en) Method for diagnosis of pharmacoresistant first-generalized epilepsy
GB0706558D0 (en) Diagnostic assay
WO2010053772A3 (en) Disease-associated antigens and methods of use thereof
UA44124U (en) Method for diagnostics of neurodegenerative diseases with the cognitive disorders